Norlevo (Levonorgestrel)

Levonorgestrel acts primarily by binding to progesterone receptors, suppressing the luteinizing hormone surge and thereby preventing or delaying ovulation. It may also modify tubal motility and endometrial lining, reducing the chance of fertilization and implantation if ovulation has already occurred.

The specific dosing regimen for Norlevo is determined by the prescribing clinician based on regulatory guidelines and the timing of exposure. Healthcare professionals select the appropriate tablet strength and timing to achieve optimal efficacy.

Norlevo is intended for use before pregnancy is established; it is not indicated for treatment of an existing pregnancy. Limited systemic exposure occurs during breastfeeding, and most guidelines consider occasional use compatible with nursing, but a clinician should be consulted.

To order Norlevo, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

The primary alternative to levonorgestrel‑based emergency contraception is ulipristal acetate, a selective progesterone receptor modulator. Ulipristal remains effective up to 120 hours after exposure, whereas levonorgestrel is most effective within 72 hours. Both are oral tablets, but their mechanisms and efficacy windows differ.

Norlevo tablets should be stored at ambient temperature, below 25 °C. Keep them in the original blister pack, protect from moisture, direct sunlight and excessive heat. Do not use tablets that appear discolored or damaged.

Norlevo is taken orally as a single tablet (or as directed by a clinician) with a glass of water. It should be swallowed whole, not chewed, and taken as soon as possible after the qualifying sexual activity.

Serious adverse events are rare but include severe allergic reactions such as rash, swelling, or breathing difficulty, and severe abdominal pain that may indicate an ectopic pregnancy. If any of these occur, seek immediate medical attention.

Norlevo should be avoided by individuals with a known hypersensitivity to levonorgestrel or any tablet excipients, by women who are already pregnant, and by those with severe liver disease without medical supervision. Consultation with a healthcare professional is essential before use.